Clinical trial
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential…
NCT00251017 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00251017 |
|---|---|
| Title | Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs |
| Official title | Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | Department of Health, Executive Yuan, R.O.C. (Taiwan) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Adverse Effects |
| Intervention type | Procedure |
| Interventions | Vancomycin, DNA are extracted from the whole blood of subjects |
| Enrollment | 34 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Nov 9, 2005 |
| Last update posted | Dec 27, 2012 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: